ARCHIVES

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

NCCS Networker Volume 1 Issue 1, March 1987

March 12, 1987

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Flint Chop Shows That Successful Community Program Can Be Developed And Operated Without NCI Funding

January 21, 1983